This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 10th-11th, 2025Boston Exhibition & Convention Center, USA
Menu

Scott Dindot
Executive Director of Molecular Genetics at Ultragenyx Pharmaceutical
Speaker

Agenda Sessions

  • Preclinical Development of an Investigational ASO Targeting the UBE3A-AS Transcript for the Treatment of Angelman Syndrome

    , 12:00pm
    View Session

At this event

Prev
Next
Gilles Divita
CSO at Aanastra/ CEO
Divincell SAS

See Scott at RNA Leaders USA